This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

Authoring team

20 µg versus >20 µg estrogen combined oral contraceptives for contraception

A systematic review was undertaken (1) and found that:

  • no differences were found in contraceptive effectiveness for 20 µg versus >20 µg estrogen combined oral contraceptives

  • compared to the higher-estrogen pills, several COCs containing 20 µg ethinyl estradiol (EE) resulted in higher rates of early trial discontinuation (overall and due to adverse events such as irregular bleeding) as well as increased risk of bleeding disturbances (both amenorrhea or infrequent bleeding and irregular, prolonged, frequent bleeding, or breakthrough bleeding or spotting)
    • cycle control may be better with COCs containing 30-35 µg EE compared with those containing 20 µg

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.